The information will be shared at the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) meeting.

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

Today we share: Hospital Data Governance System Supports Smart Hospital Construction Plan (35-page PPT) The report consists ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society ...

With the Google monopoly remedies ruling from the other day, we have more documents from the court mentioning more about ...

FibroGen has agreed to pay $1.25 million to the Securities and Exchange Commission (SEC) to address allegations that the ...

Gleneagles winning captain outlines the humble origins of the statistical work which will play a big role at Bethpage ...

In response to the needs of smart campus construction, Xi'an Medical College Library has officially launched a big data display platform, marking a solid step towards the digital and intelligent ...

By Marilyn Odendahl The Indiana Citizen September 4, 2025 At a public meeting held in Indianapolis on Wednesday to discuss ...

Tourmaline Bio (NASDAQ:TRML) on Sunday presented additional data from its ongoing Phase 2 TRANQUILITY trial of Pacibekitug in a poster presentation at the European Society of Cardiology (ESC) Congress ...

Delivering a statistically significant overall survival benefit – a critical endpoint in oncology studies – alongside the European Commission’s approval of TEVIMBRA in perioperative resectable NSCLC ...